Guardion Health Sciences Inc
NASDAQ:GHSI
Guardion Health Sciences Inc
Accounts Receivables
Guardion Health Sciences Inc
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guardion Health Sciences Inc
NASDAQ:GHSI
|
Accounts Receivables
$2.3m
|
CAGR 3-Years
510%
|
CAGR 5-Years
138%
|
CAGR 10-Years
N/A
|
|
Estee Lauder Companies Inc
NYSE:EL
|
Accounts Receivables
$1.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
B
|
Bellring Brands Inc
NYSE:BRBR
|
Accounts Receivables
$178.6m
|
CAGR 3-Years
13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Coty Inc
NYSE:COTY
|
Accounts Receivables
$500.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-4%
|
|
Inter Parfums Inc
NASDAQ:IPAR
|
Accounts Receivables
$293.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
elf Beauty Inc
NYSE:ELF
|
Accounts Receivables
$121.1m
|
CAGR 3-Years
39%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
See Also
What is Guardion Health Sciences Inc's Accounts Receivables?
Accounts Receivables
2.3m
USD
Based on the financial report for Dec 31, 2023, Guardion Health Sciences Inc's Accounts Receivables amounts to 2.3m USD.
What is Guardion Health Sciences Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
138%
Over the last year, the Accounts Receivables growth was 18%. The average annual Accounts Receivables growth rates for Guardion Health Sciences Inc have been 510% over the past three years , 138% over the past five years .